The results showed that the expression of p-MEK, p-ERK, p-p38, and p-JNK were all upregulated by ARV-771 (Figure 5A), suggesting that ARV-771 potentially activate MAPKs signaling in HCC. The gene discussed is MAP2K7; the disease is hepatocellular carcinoma.